Low incidence of livestock-associated methicillin-resistant Staphylococcus aureus bacteraemia in The Netherlands in

Brigitte A G L van Cleef1, Birgit H B van Benthem, Anja P J Haenen

  • 1Centre for Infectious Disease Control Netherlands, RIVM National Institute for Public Health and the Environment, Bilthoven, The Netherlands. brivancleef@gmail.com

Plos One
|September 7, 2013
PubMed

Insights

Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) and other MRSA infections are rare in the Netherlands. Surveillance data show low incidence rates, suggesting LA-MRSA is not currently a public health concern in the country.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health Surveillance

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) presents a global health challenge.
  • Livestock-associated MRSA (LA-MRSA), originating from pigs and calves, emerged in 2003.
  • Understanding the incidence of LA-MRSA is crucial for public health risk assessment.

Purpose of the Study:

  • To estimate the incidence of bloodstream infections (bacteremias) caused by LA-MRSA in the Netherlands.
  • To compare LA-MRSA bacteremia rates with general MRSA and all Staphylococcus aureus bacteremia.
  • To assess the current public health impact of LA-MRSA in the Netherlands.

Main Methods:

  • Utilized national surveillance data from the Netherlands for the year 2009.
  • Calculated incidence rates per 100,000 inhabitants for LA-MRSA, MRSA, and all S. aureus bacteremias.
  • Compared findings with international data on MRSA prevalence.

Main Results:

  • The incidence of LA-MRSA bacteremia was very low (0.04 episodes per 100,000 inhabitants).
  • Overall MRSA bacteremia incidence was also low (0.18 per 100,000 inhabitants) compared to all S. aureus (19.3 per 100,000).
  • LA-MRSA and MRSA were less common in the Netherlands than in many other countries.

Conclusions:

  • LA-MRSA bacteremia is uncommon in the Netherlands and does not currently represent a significant public health problem.
  • Low incidence may be attributed to distinct population exposures, potentially reduced strain virulence, or effective control policies.
  • Further investigation into population differences and strain characteristics is warranted.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...